The Norwalk viruses are a group of viruses that share certain morphologic and biochemical features and which are associated with acute gastroenteritis in humans (18) . Norwalk virus, the most extensively characterized member of this group, is a small, round, structured virus (SRSV) with a single structural protein with an Mr of approximately 59,000 (11, 15) and a single-stranded positive-sense RNA genome of at least 7.5 kb (14) . The Snow Mountain and Hawaii viruses are other SRSVs that have been detected in stool samples from outbreaks of gastroenteritis and which have been shown to cause a similar syndrome of acute gastroenteritis when administered orally to human volunteers (6, 28) . The Snow Mountain virus also appears to have a single structural protein with an Mr of approximately 62,000 (21) . Additional viruses associated with gastroenteritis and possibly related to Norwalk virus, including Taunton, Otofuke, and other SRSVs have been described previously (3, 8) . The structural and genomic characteristics of Norwalk virus are similar to those of the Caliciviridae (16) .
Further characterization of these viruses has been hampered by the lack of a system for in vitro propagation and the relatively small amounts of virus shed by infected individuals. As a result, the antigenic relationships between members within the group of Norwalk viruses are unclear. Norwalk, Snow Mountain, and Hawaii viruses can be distinguished from one another by immune electron microscopy, radioimmunoassay, and enzyme immunoassay (EIA) using postinfection human sera as reagents (1, 6, 22, (28) (29) (30) (13, 20) . Responses to multiple SRSVs have also been noted in a number of outbreaks of gastroenteritis (12, 24, 31, 32) . Each of these studies has used serologic assays in which unpurified and poorly characterized stool samples from infected individuals served as the source of antigen. The nature and potential significance of these cross-reactive or heterologous antibody responses are unclear.
The genome of the prototypic virus of this group, Norwalk virus, has been cloned, and the capsid protein has been expressed in a baculovirus expression system (14, 15) . We used baculovirus-expressed recombinant Norwalk capsid antigen (rNV) to evaluate subclass-specific antibody responses to Norwalk virus in human subjects following challenge with Norwalk, Snow Mountain, and Hawaii viruses. Sera evaluated by EIA were obtained from adults who were challenged orally with Norwalk, Snow Mountain, and Hawaii viruses in several studies that have been reported previously (20) . Sera were collected from subjects prior to challenge and 3 to 6 weeks after challenge. Subjects were observed daily for 7 days following challenge, and illness was defined as the presence of two or more episodes of vomiting or diarrhea during a 24-h period.
Subclass-specific rNV EIA was performed essentially as described elsewhere (15) , except with substitution of subclass-specific reagents for detection of bound human antibody. The production of rNV by a baculovirus recombinant that contains the 3' end of the Norwalk virus genome has been described previously (15 We also evaluated the relationship between prechallenge serum rNV antibody levels and subsequent illness or infection status in individuals challenged with Norwalk virus. The relationship between the presence or absence of detectable rNV antibody and the subsequent development of gastrointestinal illness is shown in Fig. 1 . The risk of illness was higher in individuals with preexisting antibody of any of the three subclasses. In addition, the mean log2 prechallenge serum rNV IgG titer was 10.2 + 2.5 in subjects who became ill and 7.7 + 2.6 in those who remained well (P = 0.11), and the mean level of prechallenge serum IgM and IgA was also higher in ill individuals. However, relatively few subjects remained well after Norwalk virus challenge, making assessment of the relationship between prechallenge antibody and illness difficult, and none of the differences seen were statistically significant. The risk of infection with Norwalk virus, as defined by significant antibody response or virus shedding, also was somewhat higher in subjects with evidence of prechallenge antibody (data not shown).
This study demonstrates that adults experimentally infected with Norwalk virus manifest serum IgG, IgM, and IgA responses to recombinant Norwalk virus capsid (rNV) antigen. Serum IgG EIA responses to rNV in volunteers challenged with Norwalk virus were highly correlated with responses measured previously by blocking EIA using antigen-containing stool samples from experimentally challenged volunteers (20) . This confirms the validity of the previously reported blocking EIA for the Norwalk agent (20, 22) (10) . Recently, fecal IgA responses to rNV after Norwalk virus infection have been reported (25) .
While 83% of the subjects overall had detectable prechallenge serum IgG rNV antibody (i.e., a titer of .1:80), only 21% of the subjects had serum IgM antibody titers of .1:40 and only 40% had serum IgA antibody titers of this level prior to challenge. These results are consistent with the suggestion that the duration of the serum IgA and IgM response following infection is less than that of the IgG response (5, 9, 10 (19) . If the suggestion is true, then measurement of IgM antibody may represent a relatively specific marker for Norwalk virus infection in evaluation of gastroenteritis outbreaks.
The development of methods of cloning, sequencing, and expression of the genome of the Norwalk viruses will allow performance of further studies which should completely characterize the antigenic relationships between members of this group and clarify the currently confusing information regarding resistance to infection with these viruses.
